At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,014 enrolled
Drug / intervention
Attain Success Leaddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Attain Success Clinical Trial
In Brief
An observational study evaluating Attain Success Lead for Heart Failure. Completed, enrolled 2,014 participants across 108 sites in 16 countries.
Detailed Summary
The purpose of the study is to assess lead implant success and complication rate using the Medtronic Attain Family of left-heart leads and delivery catheters.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesCanada, China, France, Germany, Hong Kong, India, Malaysia, Malta, Pakistan, Poland, Puerto Rico, Romania, Singapore, Taiwan, Thailand, United States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 2009
Enrollment StartNov 2009
Primary CompletionNov 2011
TodayJul 2026
First PostedOct 7, 2009
Enrollment StartNov 1, 2009
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 16.7 years ago
Interventions
Attain Success Leaddevice
Attain Success Lead